Bionor Holding Overview
- Year Founded
-
1985
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
- Financing Rounds
-
6
- Investments
-
2
Bionor Holding General Information
Description
Operator of a biopharmaceutical company focused on advancing proprietary therapeutic vaccines toward a functional HIV cure. The company specializes in developing diagnostic tests for viral diseases and leveraging its immunology expertise by exploring the use of its proprietary compounds for viral diseases in the development of peptide vaccines.
Contact Information
Website
www.bionorholding.comCorporate Office
- Oslo Science Park
- Gaustadalléen 21
- 0349 Oslo
- Norway
Corporate Office
- Oslo Science Park
- Gaustadalléen 21
- 0349 Oslo
- Norway
Bionor Holding Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Bionor Holding Patents
Bionor Holding Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-2984991-A1 | Dosage regimen for hiv vaccine | Inactive | 04-May-2015 | ||
| US-20180140694-A1 | Dosage regimen for hiv vaccine | Inactive | 04-May-2015 | ||
| WO-2016177833-A1 | Dosage regimen for hiv vaccine | Inactive | 04-May-2015 | ||
| JP-2018515603-A | Dosing regimen for hiv vaccine | Pending | 04-May-2015 | ||
| CA-2951616-A1 | Method for reducing and/or delaying pathological effects of human immunodeficiency virus i (hiv) or for reducing the risk of developing acquired immunodeficiency syndrome (aids) | Inactive | 11-Jul-2014 | A61K38/162 |
Bionor Holding Signals
Bionor Holding Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Bionor Holding Acquisitions (2)
Bionor Holding’s most recent deal was a Reverse Merger with Solon Eiendom. The deal was made on 15-Dec-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Solon Eiendom | 15-Dec-2016 | Reverse Merger | Real Estate Services (B2C) | ||
| Bionor Immuno | 12-Feb-2010 | Merger/Acquisition | Drug Discovery |
Bionor Holding FAQs
-
When was Bionor Holding founded?
Bionor Holding was founded in 1985.
-
Where is Bionor Holding headquartered?
Bionor Holding is headquartered in Oslo, Norway.
-
What is the size of Bionor Holding?
Bionor Holding has 7 total employees.
-
What industry is Bionor Holding in?
Bionor Holding’s primary industry is Drug Discovery.
-
Is Bionor Holding a private or public company?
Bionor Holding is a Private company.
-
What is Bionor Holding’s current revenue?
The current revenue for Bionor Holding is .
-
How much funding has Bionor Holding raised over time?
Bionor Holding has raised $69.7M.
-
Who are Bionor Holding’s investors?
Solon Eiendom has invested in Bionor Holding.
-
When was Bionor Holding acquired?
Bionor Holding was acquired on 28-Sep-2017.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process